Northpond Ventures
Latest statistics and disclosures from Northpond Ventures's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Kyverna Therapeutics, VIGL, TBIO, CADL, and represent 100.00% of Northpond Ventures's stock portfolio.
- Added to shares of these 1 stock: Kyverna Therapeutics (+$81M).
- Started 1 new stock position in Kyverna Therapeutics.
- Northpond Ventures was a net buyer of stock by $81M.
- Northpond Ventures has $103M in assets under management (AUM), dropping by 388.28%.
- Central Index Key (CIK): 0001911245
Tip: Access up to 7 years of quarterly data
Positions held by Northpond Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Northpond Ventures
Northpond Ventures holds 4 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Kyverna Therapeutics | 78.8 | $81M | NEW | 3.3M | 24.84 |
|
| Vigil Neuroscience (VIGL) | 14.0 | $14M | 4.2M | 3.41 |
|
|
| Codex Dna (TBIO) | 4.2 | $4.3M | 9.8M | 0.44 |
|
|
| Candel Therapeutics (CADL) | 3.0 | $3.1M | 1.9M | 1.58 |
|
Past Filings by Northpond Ventures
SEC 13F filings are viewable for Northpond Ventures going back to 2021
- Northpond Ventures 2024 Q1 filed May 15, 2024
- Northpond Ventures 2023 Q4 filed Feb. 14, 2024
- Northpond Ventures 2023 Q3 filed Nov. 14, 2023
- Northpond Ventures 2023 Q2 filed Aug. 14, 2023
- Northpond Ventures 2023 Q1 filed May 15, 2023
- Northpond Ventures 2022 Q4 filed Feb. 1, 2023
- Northpond Ventures 2022 Q3 filed Nov. 14, 2022
- Northpond Ventures 2022 Q2 filed Aug. 1, 2022
- Northpond Ventures 2022 Q1 filed May 16, 2022
- Northpond Ventures 2021 Q4 filed Feb. 15, 2022